ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Incidence of Donor-Specific Anti-HLA Antibodies in Non-HLA Sensitized Patients Given Tacrolimus Once or Twice Daily During the First Two Years Post-Transplantation.

N. Kamar, V. Hajj, I. Ferrandiz, E. Younes, L. Esposito, A. Hébral, A. Del Bello.

Department of Nephrology and Organ Transplantation, Toulouse University Hospital, Toulouse, France

Meeting: 2017 American Transplant Congress

Abstract number: B81

Keywords: Alloantibodies, Immunosuppression, Rejection

Session Information

Session Name: Poster Session B: Antibody Mediated Rejection in Kidney Transplant Recipients II

Session Type: Poster Session

Date: Sunday, April 30, 2017

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Hall D1

Donor-specific anti-HLA antibody (DSA)-mediated rejection (AMR) is a main cause of graft loss after kidney transplantation. Non-adherence is a risk factor for AMR and graft loss. Large intra-patient variability from calcineurin inhibitor intake (IPV) is associated with worse kidney-allograft survival. Adherence and IPV are significantly better in kidney-transplant patients given once daily tacrolimus (Advagraf®, ADV) compared to those receiving tacrolimus b.i.d (Prograf®, PRG). The aim of this retrospective study was to compare the incidences of DSAs in de novo kidney-transplant patients given PRG or ADV.

Between 1/2009 and 12/2013, all de novo non-HLA sensitized patients who had received a first isolated kidney transplantation in our center and that had received mycophenolic acid (MPA) and either PRG (n=168) or ADV (n=82), were included in the study. Anti-HLA antibodies were assessed before transplantation, and at 6, 12, 18, and 24 months post-transplantation, at each time patients presented with kidney-function impairment, assessed using the Luminex SA assay.

Significantly more patients that received PRG, compared to ADV, received an induction therapy, maintenance steroids and MPA at 1 and 2 years. At 2-years posttransplant, the incidences of DSAs were 3.57% under PRG and 1.2% under ADV (ns). Histological features of AMR with and without DSAs were 2.4% under PRG and 6% under ADV (ns). The incidence of T-cell mediated rejection was 8.3% under PRG and 17% under ADV (p=0.06). The patients' and graft-survival rates, IPV, and kidney function at 12 and 24 months, and infection rates were similar in both groups.

In conclusion, patients given tacrolimus and MPA had a similar low incidence of DSAs at 2 years post-transplantation, and no difference was observed between patients given Prograf or Advagraf.

CITATION INFORMATION: Kamar N, Hajj V, Ferrandiz I, Younes E, Esposito L, Hébral A, Del Bello A. Incidence of Donor-Specific Anti-HLA Antibodies in Non-HLA Sensitized Patients Given Tacrolimus Once or Twice Daily During the First Two Years Post-Transplantation. Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Kamar N, Hajj V, Ferrandiz I, Younes E, Esposito L, Hébral A, Bello ADel. Incidence of Donor-Specific Anti-HLA Antibodies in Non-HLA Sensitized Patients Given Tacrolimus Once or Twice Daily During the First Two Years Post-Transplantation. [abstract]. Am J Transplant. 2017; 17 (suppl 3). https://atcmeetingabstracts.com/abstract/incidence-of-donor-specific-anti-hla-antibodies-in-non-hla-sensitized-patients-given-tacrolimus-once-or-twice-daily-during-the-first-two-years-post-transplantation/. Accessed May 9, 2025.

« Back to 2017 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences